XML 39 R36.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share-Based Compensation (Detail) (USD $)
In Millions, except Share data, unless otherwise specified
0 Months Ended 3 Months Ended 9 Months Ended 0 Months Ended 9 Months Ended 4 Months Ended 9 Months Ended
Dec. 17, 2008
Stock Appreciation Rights (SARs) [Member]
Mar. 24, 2012
Stock Appreciation Rights (SARs) [Member]
Oct. 06, 2012
Stock Appreciation Rights (SARs) [Member]
Oct. 06, 2012
Time Vesting Equity Units[Member]
Oct. 06, 2012
Performance Vesting Units[Member]
Dec. 31, 2011
LTIP [Member]
2009 Plan [Member]
Oct. 06, 2012
LTIP [Member]
2012 Plan [Member]
Oct. 06, 2012
Selling, General and Administrative Expenses [Member]
Oct. 08, 2011
Selling, General and Administrative Expenses [Member]
Oct. 06, 2012
Selling, General and Administrative Expenses [Member]
Oct. 08, 2011
Selling, General and Administrative Expenses [Member]
Allocated Share-based Compensation Expense (in Dollars)               $ 2.9 $ 1.8 $ 1.3 $ 4.3
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures     23,800     90,670          
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 267,345           209,693        
Percentage Of Number Of Performance Units Granted In Shares             zero to 200%        
Share-based Compensation Arrangement by Share-based Payment Award, Other Than Options, Outstanding, Weighted Average Exercise Price (in Dollars per share) $ 38.44   $ 38.44                
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number     267,345                
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations     243,545                
Deferred Tax Asset Write Off (in Dollars)   $ 0.8                  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)       $ 23.03 $ 29.19